hemotune AG initiates joint feasibility project on the HemoSystem with AstraZeneca
24-03-2023 – hemotune AG, known for its magnetic blood purification platform, announces a joint feasibility project with the global pharmaceutical company AstraZeneca.
The feasibility project is based on the HemoSystem, a therapeutic blood purification platform under development by hemotune which is designed for selective and efficient removal of large biomolecules directly from blood. For hemotune CEO Lukas Langenegger the project confirms the achievements of hemotune as well as the need the start-up addresses with its platform.
